Mercado europeu de controlos de diagnóstico molecular – Tendências do setor e previsão para 2028

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Healthcare Europe Molecular Diagnostic Controls Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado europeu de controlos de diagnóstico molecular – Tendências do setor e previsão para 2028

  • Healthcare
  • Publish Reports
  • Aug 2021
  • Europe
  • 350 Páginas
  • Número de tabelas: 102
  • Número de figuras: 47
Comprar agora Comprar agora

>Mercado europeu de controlos de diagnóstico molecular, por produto (controlos independentes, controlos específicos de instrumentos), tipo de analito (controlos de analito único, controlos de múltiplos analitos), aplicação (doenças infeciosas, oncologia, testes genéticos, outros), utilizador final (laboratórios clínicos, hospitais, Fabricantes de IVD e organizações de investigação por contrato, institutos académicos e de investigação, outros), canal de distribuição (venda a retalho, concurso direto), país (Alemanha, Reino Unido, França, Itália, Espanha, Países Baixos , Rússia, Suíça, Bélgica, Turquia e resto da Europa)) Tendências e previsões da indústria para 2028.

Mercado Europeu de Controlos de Diagnóstico MolecularAnálise de Mercado e Insights: Mercado Europeu de Controlos de Diagnóstico Molecular

Espera-se que o mercado europeu de controlos de diagnóstico molecular ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 8,4% no período de previsão de 2021 a 2028 e prevê-se que atinja os 112,09 milhões de USD até 2028. O aumento do avanço tecnológico e o aumento dos gastos em saúde são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.

O diagnóstico molecular é o ramo da medicina laboratorial ou patologia clínica que utiliza para analisar marcadores biológicos no proteoma e no genoma. Utiliza a biologia molecular para analisar a expressão das células no gene como proteína para a previsão de doenças, selecionar tratamentos e monitorizar a eficácia das terapias. O controlo de diagnóstico molecular é o processo de verificação da pureza e eficiência de qualquer reagente que fornece uma vasta gama de serviços de avaliação de qualidade focados principalmente nas doenças infeciosas moleculares .

O mercado de controlos de qualidade molecular está a ser impulsionado por uma mudança no foco dos intervenientes no mercado no sentido do desenvolvimento de testes de diagnóstico molecular para detecção de doenças infecciosas e detecção de cancro; um aumento da adopção pelo utilizador final de controlos de qualidade de terceiros, um aumento do número de laboratórios clínicos acreditados e um aumento da procura de apoio externo à avaliação da qualidade. No entanto, projeta-se que o mercado dos controlos de qualidade molecular seja prejudicado por um ambiente de reembolso desfavorável para os testes de diagnóstico molecular, custos elevados associados ao procedimento de controlo de qualidade e restrições orçamentais dos utilizadores finais, como hospitais e laboratórios clínicos.

O relatório do mercado de controlos de diagnóstico molecular fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos. Para compreender a análise e o cenário do mercado contacte-nos para um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado europeu de controlos de diagnóstico molecularO diagnóstico molecular da Europa controla o âmbito do mercado e o tamanho do mercado

O mercado de controlos de diagnóstico molecular da Europa, África e Índia está categorizado em cinco segmentos notáveis ​​que se baseiam no produto, tipo de analito, aplicação, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

  • Com base no produto, o mercado europeu de controlos de diagnóstico molecular está segmentado em controlos independentes e controlos específicos de instrumentos. Em 2021, prevê-se que o segmento dos controlos independentes domine o mercado dos controlos de diagnóstico molecular porque cada vez mais laboratórios começam a utilizar controlos de terceiros como parte da sua estratégia diária de CQ.
  • Com base no analito, o mercado europeu de controlos de diagnóstico molecular está segmentado em controlos de analito único e controlos de múltiplos analitos. Em 2021, prevê-se que o segmento dos controlos de analito único domine o mercado dos controlos de diagnóstico molecular devido à sua relação custo-benefício.
  • Com base na aplicação, o mercado europeu de controlos de diagnóstico molecular está segmentado em doenças infeciosas, oncologia, testes genéticos e outras aplicações. Em 2021, prevê-se que o segmento das doenças infeciosas domine o mercado dos controlos de diagnóstico molecular devido à crescente prevalência de doenças infeciosas.
  • Com base no utilizador final, o mercado europeu de controlos de diagnóstico molecular está segmentado em laboratórios clínicos, hospitais, fabricantes de IVD e organizações de investigação por contrato, institutos académicos e de investigação e outros utilizadores finais. Em 2021, prevê-se que o segmento dos laboratórios clínicos domine o mercado dos controlos de diagnóstico molecular devido ao aumento do número de laboratórios clínicos acreditados.
  • Com base no canal de distribuição, o mercado europeu de controlos de diagnóstico molecular está segmentado em concurso direto e vendas a retalho. Em 2021, prevê-se que o segmento de vendas a retalho domine o mercado dos controlos de diagnóstico molecular devido à flexibilidade para adquirir uma quantidade limitada de testes de acordo com as suas necessidades, em vez de concursos em massa.

Mercado Europeu de Controlos de Diagnóstico MolecularAnálise molecular do mercado de controlos de diagnóstico a nível de país

O mercado de controlos de diagnóstico molecular da Europa, África e Índia está categorizado em cinco segmentos notáveis ​​que se baseiam no produto, tipo de analito, aplicação, utilizador final e canal de distribuição.

The countries covered in the Europe molecular diagnostic controls market report are Germany, France, U.K., Italy, Germany, Spain, Netherlands, Russia, Switzerland, Turkey and rest of Europe.

Germany is the dominating country of the Europe Molecular diagnostic controls market due to high technological advancement for healthcare.

Independent controls segment in European region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of the more and more laboratories are beginning to use third party controls as part of their daily QC strategy. Germany is the dominating country with leading growth in the market and independent controls segment because of increasing investment in innovative R&D for novel biomarker product. U.K. is the second leading country and independent controls segment is dominating the market owing to advancements in the disease detection. France is the third largest shareholder country because rising private funding and industry market player interest for the investment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increasing chronic diseases prevalence and technological advancements are boosting the market growth of Molecular Diagnostic Controls. 

Molecular diagnostic controls market also provides you with detailed market analysis for every country growth in molecular diagnostic controls industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the molecular diagnostic controls market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Molecular Diagnostic Controls Market Share Analysis

Molecular diagnostic controls market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to molecular diagnostic controls market.

As principais empresas que operam no mercado europeu de controlos de diagnóstico molecular são a Thermo Fisher Scientific Inc., ASURAGEN, INC., Technopath Clinical Diagnostics, Helena Laboratories (UK) Limited trading, ELITechGroup, EKF Diagnostics Holdings plc, Merck KGaA, SERACARE LIFE SCIENCES , Quidel Corporation, QNOSTICS, Randox Laboratories Ltd., Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott e Microbiologics, entre outros.

Muitos lançamentos e acordos de produtos são também iniciados pelas empresas de todo o mundo, que também estão a acelerar o mercado dos controlos de diagnóstico molecular.

Por exemplo,

  • Em julho de 2021, a Thermo Fisher Scientific Inc. anunciou que colaborou com a Ortho Clinical Diagnostics para promover e distribuir os controlos de qualidade MAS da Thermo Scientific e o software de garantia de qualidade LabLink xL para utilização com os analisadores VITROS da Ortho Clinical Diagnostics . Esta colaboração feita pela empresa aumentou as suas vendas e procura no mercado levando a um aumento de receitas no futuro
  • Em maio de 2020, a Technopath Clinical Diagnostics anunciou que lançou o seu novo produto denominado Multichem ID-COVID-19 Quality Control Solutions. Este novo produto lançado pela empresa aumentou a sua credibilidade no mercado em tempos de COVID-19
  • Em setembro de 2020, a Abbott lançou o Teste Rápido Panbio COVID-19 em França para apoiar a deteção de doentes com COVID-19 em rápido crescimento em França. Este lançamento de teste de diagnóstico por parte da empresa aumentou a sua credibilidade no mercado

A colaboração, o lançamento de produtos, a expansão do negócio, a premiação e o reconhecimento, as joint ventures e outras estratégias do player de mercado estão a melhorar o mercado da empresa no mercado dos Controlos de Diagnóstico Molecular, que também oferece o benefício para a organização melhorar a sua oferta de Controlos de Diagnóstico Molecular.

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe molecular diagnostic controls market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. REGULATIONS OF EUROPE, AFRICA, AND INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET
  6. market overview
    1. DRIVERS
      1. INCREASE IN PREVALENCE OF INFECTIOUS DISEASES AND CANCER
      2. GROWING ADOPTION OF THIRD-PARTY QUALITY CONTROLS
      3. RISE IN CLEARANCE FROM REGULATORY AGENCIES
      4. INCREASE IN NUMBER OF ACCREDITED CLINICAL LABORATORIES
    2. RESTRAINT
      1. HIGH COSTS ASSOCIATED WITH QUALITY CONTROL PROCESS
    3. OPPORTUNITIES
      1. COLLABORATIONS BETWEEN ACADEMIC INSTITUTIONS, HOSPITALS, AND COMPANIES
      2. INCREASE IN RESEARCH ON CANCER BIOMARKERS
      3. ADVANCED DIAGNOSIS INFRASTRUCTURE
    4. CHALLENGE
      1. UNFAVORABLE REIMBURSEMENT POLICIES FOR MOLECULAR TESTS
  7. IMPACT OF COVID-19 ON EUROPE MOLECULAR DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19
    5. CONCLUSION
  8. Europe molecular diagnostic controls MARKET, BY PRODUCT
    1. overview
    2. Independent Controls
    3. Instrument Specific Controls
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. DNA Sequencing & Next Generation Sequencing
      4. In Situ Hybridization (ISH)
      5. DNA Microarray
  9. Europe molecular diagnostic controls MARKET, BY analyte TYPE
    1. overview
    2. Single Analyte Controls
    3. Multi Analyte Controls
  10. Europe molecular diagnostic controls MARKET, BY application
    1. overview
    2. Infectious Disease
      1. Hepatitis
      2. Human papillomavirus (HPV)
      3. HIV
      4. Health care-associated infections (HAIs)
      5. Influenza
      6. Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG)
      7. TB
      8. Others
    3. Oncology
    4. Genetic Testing
    5. Others
  11. Europe molecular diagnostic controls MARKET, BY end user
    1. overview
    2. Clinical Laboratories
    3. Hospitals
    4. IVD Manufacturers & Contract Research Organisations
    5. Academic & Research Institutes
    6. Others
  12. Europe molecular diagnostic controls MARKET, BY distribution channel
    1. overview
    2. Retail Sales
    3. Direct Tenders
  13. Europe Molecular Diagnostic Controls Market, By Region
    1. Europe
    2. EUROPE
      1. Germany
      2. U.K.
      3. FRANCE
      4. ITALY
      5. SPAIN
      6. nETHERLANDS
      7. SWITZERLAND
      8. RUSSIA
      9. BELGIUM
      10. TURKEY
      11. REST OF EUROPE
  14. EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, COMPANY landscape
    1. company share analysis: EUROPE
  15. swot analysis
  16. Company profile
    1. Bio-Rad Laboratories, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    2. Randox Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    3. Technopath Clinical Diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    4. Thermo fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. ASURAGEN, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. BIOMÉRIEUX SA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. EKF Diagnostics Holdings plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. ELITechGroup
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Helena Laboratories (UK) Limited trading
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. microbiologics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Molbio Diagnostics Pvt. Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. SERACARE LIFE SCIENCES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. QNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. QUIDEL CORPORATION
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

Lista de Tabela

TABLE 1 Europe molecular diagnostic controls Market, By product, 2019-2028 (USD MILLION)

TABLE 2 Europe Independent Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 3 Europe Instrument Specific Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 4 Europe Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 5 Europe molecular diagnostic controls Market, By Analyte type, 2019-2028 (USD MILLION)

TABLE 6 Europe Single Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Multi Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 8 Europe molecular diagnostic controls Market, By application, 2019-2028 (USD MILLION)

TABLE 9 Europe Infectious Disease in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 10 Europe Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 11 Europe Oncology in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 12 Europe Genetic Testing in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 13 Europe Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe molecular diagnostic controls Market, By end user, 2019-2028 (USD MILLION)

TABLE 15 Europe Clinical Laboratories in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 16 Europe Hospitals in Molecular Diagnostic Controls Market, By Region r, 2019-2028 (USD Million)

TABLE 17 Europe IVD Manufacturers & Contract Research Organisations in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 18 Europe Academic & Research Institutes in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 19 Europe Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 20 Europe molecular diagnostic controls Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 21 Europe Retail Sales in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Direct Tenders in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 23 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, by Region, 2019-2028 (USD Million)

TABLE 24 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 25 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 26 EUROPE Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 27 EUROPE Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 28 EUROPE Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 29 EUROPE Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 30 EUROPE Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 31 EUROPE Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 32 GERMANY MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 33 Germany Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 34 Germany Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 35 Germany Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 36 Germany Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 37 Germany Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 38 Germany Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 39 U.K. MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 40 U.K. Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 41 U.K. Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 42 U.K. Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 43 U.K. Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 44 U.K. Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 45 U.K. Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 46 FRANCE MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 47 FRANCE Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 48 FRANCE Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 49 FRANCE Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 50 FRANCE Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 51 FRANCE Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 52 FRANCE Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 53 ITALY MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 54 ITALY Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 55 ITALY Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 56 ITALY Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 57 ITALY Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 58 ITALY Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 59 ITALY Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 SPAIN MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 61 SPAIN Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 62 SPAIN Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 63 SPAIN Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 64 SPAIN Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 65 SPAIN Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 66 SPAIN Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 67 NETHERLANDS MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 68 NETHERLANDS Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 69 NETHERLANDS Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 70 NETHERLANDS Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 71 NETHERLANDS Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 72 NETHERLANDS Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 73 NETHERLANDS Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 SWITZERLAND MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 75 SWITZERLAND Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 76 SWITZERLAND Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 77 SWITZERLAND Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 78 SWITZERLAND Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 79 SWITZERLAND Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 80 SWITZERLAND Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 81 RUSSIA MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 82 RUSSIA Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 83 RUSSIA Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 84 RUSSIA Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 85 RUSSIA Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 86 RUSSIA Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 87 RUSSIA Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 88 BELGIUM MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 89 BELGIUM Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 90 BELGIUM Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 91 BELGIUM Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 92 BELGIUM Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 93 BELGIUM Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 94 BELGIUM Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 TURKEY MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 96 TURKEY Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 97 TURKEY Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 98 TURKEY Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 99 TURKEY Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 100 TURKEY Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 101 TURKEY Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 REST OF EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

Lista de Figura

FIGURE 1 Europe molecular diagnostic controls MARKET: SEGMENTATION

FIGURE 2 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: DATA TRIANGULATION

FIGURE 3 Europe molecular diagnostic controls market: DROC ANALYSIS

FIGURE 4 Europe molecular diagnostic controls market: Global VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe molecular diagnostic controls market: COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe molecular diagnostic controls market: MULTIVARIATE MODELLING

FIGURE 7 Europe molecular diagnostic controls market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 Europe molecular diagnostic controls market: MARKET application COVERAGE GRID

FIGURE 11 Europe molecular diagnostic controls market: SEGMENTATION

FIGURE 12 Europe is expected to DOMINATE THE Europe molecular diagnostic controls market AND india IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 increasing prevalence of infectious diseases and cancer is expected to DRIVe THE Europe molecular diagnostic controls market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 product SEGMENT is expected to account for the largest share of the Europe molecular diagnostic controls MARKET in 2021 & 2028

FIGURE 15 InDIA is the fastest growing market FOR the Europe Molecular diagnostic controls MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF Europe molecular diagnostics controls Market

FIGURE 17 Europe molecular diagnostic controls MARKET: BY product, 2020

FIGURE 18 Europe molecular diagnostic controls MARKET: BY product, 2021-2028 (USD MILLION)

FIGURE 19 Europe molecular diagnostic controls MARKET: BY product, CAGR (2021-2028)

FIGURE 20 Europe molecular diagnostic controls MARKET: BY product, LIFELINE CURVE

FIGURE 21 Europe molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2020

FIGURE 22 Europe molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2021-2028 (USD MILLION)

FIGURE 23 Europe molecular diagnostic controls MARKET: BY ANALYTE TYPE, CAGR (2021-2028)

FIGURE 24 Europe molecular diagnostic controls MARKET: BY ANALYTE TYPE, LIFELINE CURVE

FIGURE 25 Europe molecular diagnostic controls MARKET: BY application, 2020

FIGURE 26 Europe molecular diagnostic controls MARKET: BY application, 2021-2028 (USD MILLION)

FIGURE 27 Europe molecular diagnostic controls MARKET: BY application, CAGR (2021-2028)

FIGURE 28 Europe molecular diagnostic controls MARKET: BY application, LIFELINE CURVE

FIGURE 29 Europe molecular diagnostic controls MARKET: BY end user, 2020

FIGURE 30 Europe molecular diagnostic controls MARKET: BY end user, 2021-2028 (USD MILLION)

FIGURE 31 Europe molecular diagnostic controls MARKET: BY end user, CAGR (2021-2028)

FIGURE 32 Europe molecular diagnostic controls MARKET: BY end user, LIFELINE CURVE

FIGURE 33 Europe molecular diagnostic controls MARKET: BY distribution channel, 2020

FIGURE 34 Europe molecular diagnostic controls MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 35 Europe molecular diagnostic controls MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 36 Europe molecular diagnostic controls MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 37 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET: SNAPSHOT (2020)

FIGURE 38 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2020)

FIGURE 39 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 Europe MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY PRODUCT (2021-2028)

FIGURE 42 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: SNAPSHOT (2020)

FIGURE 43 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2020)

FIGURE 44 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 45 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 46 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: BY PRODUCT (2021-2028)

FIGURE 47 EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Navegue pelas páginas relacionadas

Banner